GJA6P

Across TCGA pan-cancer cohorts, GJA6P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of GJA6P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where GJA6P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GJA6P is over-expressed in tumor.

STAD are the cancer types where GJA6P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GJA6P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	II,III,IV	+0.041	.009	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

GJA6P–STAD

Open the STAD breakdown →